3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Breast Neoplasms
37
Melanoma
17
Prostatic Neoplasms
16
Lung Neoplasms
14
Neoplasms
13
Squamous Cell Carcinoma of Head and Neck
10
Neoplasm Metastasis
9
Carcinoma, Non-Small-Cell Lung
9
Precancerous Conditions
8
Lymphoma
8
Uterine Cervical Neoplasms
6
Pancreatic Neoplasms
6
Leukemia
6
Esophageal Neoplasms
6
Colorectal Neoplasms
6
Colonic Neoplasms
6
Breast Neoplasms, Male
6
Urinary Bladder Neoplasms
5
Rectal Neoplasms
5
Myelodysplastic Syndromes
5
Lymphoma, Follicular
5
Leukemia, Myeloid, Acute
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Head and Neck Neoplasms
5
Barrett Esophagus
5
Adenocarcinoma Of Esophagus
5
Salivary Gland Neoplasms
4
Recurrence
4
Multiple Myeloma
4
Lymphoma, Non-Hodgkin
4
Interventions
Propranolol
6
Prednisolone
3
Timolol
2
Steroids
2
Saline Solution
2
Prednisone
2
Adrenergic beta-Antagonists
2
Urine Specimen Collection
1
Therapeutics
1
Sodium Chloride
1
Sirolimus
1
Nadolol
1
Methylprednisolone
1
Leuprolide
1
Lasers, Semiconductor
1
Imiquimod
1
High-Energy Shock Waves
1
Hepatectomy
1
Gels
1
Bleomycin
1
Biopsy
1
Atenolol
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Hemangioma
×
Biopsy
×
Clear all
NCT02334930
2016-08-22
PEC-Hem
University Hospital, Bordeaux
Completed
13 enrolled